Andrzejczak Dariusz, Kocon Katarzyna, Zieba Remigiusz
Department of Pharmacodynamics, Medical University of Łódź, Łódź, Poland.
Basic Clin Pharmacol Toxicol. 2008 Nov;103(5):450-4. doi: 10.1111/j.1742-7843.2008.00310.x. Epub 2008 Aug 11.
Mirtazapine is a noradrenergic and specific serotonergic antidepressant. The influence of the drug on the cardiovascular system has not been definitely determined. Therefore, we made an attempt to evaluate the influence of chronic administration of mirtazapine on the hypotensive action of a single administered dose of propranolol and enalapril in spontaneously hypertensive rats. The animals were divided into eight experimental groups. Mirtazapine (5 and 10 mg/kg) was administered intraperitoneally for 14 days. Twenty-four hours after the last administration of the drug, the rats received a single intraperitoneal dose of hypotensive drugs (propranolol 5 mg/kg or enalapril 10 mg/kg) or 1% solution of methylcellulose. Mirtazapine administered chronically did not affect the hypotensive effect of a single dose of propranolol or enalapril in spontaneously hypertensive rats. It seems that mirtazapine could be a useful drug in patients with depression accompanied by hypertension.
米氮平是一种去甲肾上腺素能和特异性5-羟色胺能抗抑郁药。该药对心血管系统的影响尚未明确确定。因此,我们试图评估长期给予米氮平对自发性高血压大鼠单次给予普萘洛尔和依那普利降压作用的影响。动物被分为八个实验组。米氮平(5和10毫克/千克)腹腔注射给药14天。在最后一次给药后24小时,大鼠接受单次腹腔注射降压药物(普萘洛尔5毫克/千克或依那普利10毫克/千克)或1%甲基纤维素溶液。长期给予米氮平对自发性高血压大鼠单次剂量普萘洛尔或依那普利的降压作用没有影响。米氮平似乎可能是伴有高血压的抑郁症患者的一种有用药物。